Abstract:Bioorthogonal catalysts based on metal complexes have gained substantial progress during recent years. Diversified delivery routes, including nanoparticles, hydrogels, exosomes, and removable microneedle patches, have provided efficient and biocompatible ways for in vivo transportation of bioorthogonal systems. A proximal decaging strategy via biorthogonal catalysis achieved time-resolved protein activation in living systems and enriched the toolbox for indirect protein engineering. The efficacy of bioorthogonal catalysis has been explored in the activation of antimicrobial reagents. Bioorthogonal catalysis has been applied to cell engineering by triggering the transformation of chemical groups on cell membranes, thus providing a feasible toolkit to regulate cell status. Bioorthogonal chemistry, referring to chemical reactions occurring in a physiological environment without interfering with native biochemical reactions, has witnessed substantial progress during the past few decades. To date, bioorthogonal chemistry has achieved wide applications in biomedical practices, including prodrug activation, protein transformation, and cellular engineering. Here, we review the development and recent advances of bioorthogonal chemistry, with an emphasis on the biomedical application of bioorthogonal catalysis, aiming to provide an overview of the evolution and challenges in this field. Bioorthogonal chemistry, referring to chemical reactions occurring in a physiological environment without interfering with native biochemical reactions, has witnessed substantial progress during the past few decades. To date, bioorthogonal chemistry has achieved wide applications in biomedical practices, including prodrug activation, protein transformation, and cellular engineering. Here, we review the development and recent advances of bioorthogonal chemistry, with an emphasis on the biomedical application of bioorthogonal catalysis, aiming to provide an overview of the evolution and challenges in this field. cycloaddition reaction that takes place between electron-rich dienophile and electron-deficient diene. a strategy that could covalently attach molecules to nucleophilic amino acid residues located near the ligand-binding site. a modification of the classic Staudinger reduction of azides with triphenylphosphine. metal-free cycloadditions between strained cyclooctynes and azides that give stable 1,2,3-triazoles.

Bioorthogonal chemistry for prodrug activation in vivo

Enzymatic Non-Covalent Synthesis of a Versatile Platform for Bioorthogonal Prodrugs Activation to Combat Drug Resistance

Enzymatic non-covalent synthesis of supramolecular assemblies as a general platform for bioorthogonal prodrugs activation to combat drug resistance

Bioorthogonal Chemistry-Based Prodrug Strategies for Enhanced Biosafety in Tumor Treatments: Current Progress and Challenges

Synergistic Enzymatic and Bioorthogonal Reactions for Selective Prodrug Activation in Living Systems

Bioorthogonal Catalysis for Biomedical Applications

Bioorthogonal prodrug activation driven by a strain-promoted 1,3-dipolar cycloaddition

Tetrazine-mediated bioorthogonal prodrug–prodrug activation

A Dual-Mechanism Targeted Bioorthogonal Prodrug Therapy

A High‐Efficiency Bioorthogonal Tumor‐Membrane Reactor for In Situ Selective and Sustained Prodrug Activation

Bioorthogonal Prodrug–Antibody Conjugates for On-Target and On-Demand Chemotherapy

Bioorthogonal PROTAC Prodrugs Enabled by On-Target Activation

Prodrug activation by 4,4'-bipyridine-mediated aromatic nitro reduction

Development and Application of Bioorthogonal Reactions for Drug Imaging and Activation

Palladium-Mediated Bioorthogonal System for Prodrug Activation of N -Benzylbenzamide-Containing Tubulin Polymerization Inhibitors for the Treatment of Solid Tumors

Recent Advances in Developing Active Targeting and Multi-Functional Drug Delivery Systems Via Bioorthogonal Chemistry

An all-in-one tetrazine reagent for cysteine-selective labeling and bioorthogonal activable prodrug construction

Development Of Bioorthogonal Reactions And Their Applications In Bioconjugation

Hydrogen-bonded organic framework-based bioorthogonal catalysis prevents drug metabolic inactivation

Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy

Controlled bioorthogonal activation of Bromodomain-containing protein 4 degrader by co-delivery of PROTAC and Pd-catalyst for tumor-specific therapy